FMP

FMP

Enter

IDYA - IDEAYA Bio...

photo-url-https://images.financialmodelingprep.com/symbol/IDYA.png

IDEAYA Biosciences, Inc.

IDYA

NASDAQ

IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, a protein kinase C inhibitor that is in Phase I/II clinical trial for genetically defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes various synthetic lethality programs targeting PARG inhibitor in tumors for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures; Pol Theta inhibitors in tumors with BRCA or other homologous recombination deficiency mutations; and WRN inhibitors in tumors with high microsatellite instability. The company has a research collaboration agreement with Cancer Research UK and the University of Manchester to develop small molecule inhibitors of Poly (ADP-ribose) glycohydrolase; and a clinical trial collaboration and supply agreement with Pfizer Inc. for Phase I/II study in metastatic uveal melanoma, skin melanoma, and other solid tumors, as well as a strategic partnership with GlaxoSmithKline plc. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

23.14 USD

-0.01 (-0.04322%)

Build Up Free Cash Flow

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Revenue

132.51M

170.36M

310.02M

363.14M

414.29M

561.12M

760M

1.03B

1.39B

1.89B

Operating Cash Flow

-34.25M

-25.23M

-62.35M

-40.7M

-16.17M

-85.16M

-115.34M

-156.22M

-211.58M

-286.57M

Cap Ex

-3.31M

-2.37M

-3.62M

-7.23M

-12.48M

-11.29M

-15.29M

-20.71M

-28.05M

-37.99M

Free Cash Flow

-37.56M

-27.6M

-65.97M

-47.93M

-28.65M

-96.45M

-130.63M

-176.93M

-239.63M

-324.56M

Wacc

10.9

10.9

10.9

10.9

10.9

Pv Lfcf

-86.97M

-106.22M

-129.73M

-158.44M

-193.51M

Sum Pv Lfcf

-674.87M

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep